The Pharma Wholesale and Distribution Market Report 2021-2031: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Distributors Invest Substantially In Support Of Infrastructure In The Supply Chain Just As Health Care Organizations
Distributors are making significant investments to help tame the supply chain infrastructure, just as healthcare systems continue to invest in internal systems and processes to improve their ability to anticipate and respond to dynamic conditions. Forward-thinking distributors are ready to move with agility by improving system efficiencies, streamlining business processes, and employing and developing talented team members. Drug shortages are unavoidable, and even under the most vigilant surveillance, they will occur. When they do, some distributors already have a specialised team and system in place to locate backup inventory for short-term supply shortages, which they can use in conjunction with existing inventory management standards. In order to make timely, well-informed judgments based on product-specific knowledge, savvy distributors also maintain excellent supplier connections. These are just a few of the tactics that help to ensure a consistent supply at a reasonable price.
Increase In Maintenance And Cost Control
Despite the fact that both generic and brand-name drugs are prone to shortages, generic products may be more sensitive to production problems. Generic medications are often produced on the same line as a variety of other items, and redundancy is not frequently built into their processes. When a common generic drug becomes unavailable, healthcare providers must consider if the most effective option is a more expensive name brand. They may also have to pay more for people to manage pharmacy automation systems and EMR adjustments that may be necessary when alternative prescriptions must be prescribed.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the pharma wholesale and distribution market evolving?
• What is driving and restraining the pharma wholesale and distribution market?
• How will each pharma wholesale and distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2031?
• How will the market shares for each pharma wholesale and distribution submarket develop from 2021 to 2031?
• What will be the main driver for the overall market from 2021 to 2031?
• Will leading pharma wholesale and distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2031 and which geographical region will lead the market in 2031?
• Who are the leading players and what are their prospects over the forecast period?
• What are the pharma wholesale and distribution projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2031?
• What are the implication of pharma wholesale and distribution projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the pharma wholesale and distribution market?
• Where is the pharma wholesale and distribution market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the pharma wholesale and distribution market today, and over the next 10 years:
• Our 457-page report provides 300 tables and 284 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the pharma wholesale and distribution market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharma wholesale and distribution prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Global Pharma Wholesale and Distribution Market (COVID Impact Analysis) by Type
• Full-Line Wholesalers (FLWs)
• Short-Line Wholesalers (SLWs)
• Direct-to-Pharmacy (DTP)
• Hospitals, Clinics & Others
• Mail Orders
• Other Types
Global Pharma Wholesale and Distribution Market (COVID Impact Analysis) by Distributor Type
• Ethical/Branded Pharma Products Distributors
• Generic Pharma Products Distributors
• Propaganda Cum Distribution (PCD) Franchise
• OTC/Institutional Supply Pharma Distributors
• Other Distributor Types
Global Pharma Wholesale and Distribution Market (COVID Impact Analysis) by Product Type
• Prescription Drugs Wholesaling & Distribution
• OTC Products Wholesaling & Distribution
• Antibiotics wholesaling & Distribution
• Antiseptics Wholesaling & Distribution
• Supplement Products Wholesaling & Distribution
• Other Product Types
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:
• North America Pharma Wholesale and Distribution Market, 2021 to 2031 Market Outlook
• U.S. Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Canada Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Mexico Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Europe Pharma Wholesale and Distribution Market, 2021 to 2031 Market Outlook
• Germany Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Spain Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• United Kingdom Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• France Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Italy Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Europe Market Forecast & COVID Impact Analysis
• Asia Pacific Pharma Wholesale and Distribution Market, 2021 to 2031 Market Outlook
• China Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Japan Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• India Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Australia Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Korea Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Asia Pacific Market Forecast & COVID Impact Analysis
• LAMEA Pharma Wholesale and Distribution Market, 2021 to 2031 Market Outlook
• Brazil Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Turkey Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Saudi Arabia Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Africa Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• UAE Pharma Wholesale and Distribution Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Latin America, Middle East and Africa
The report also includes profiles and for some of the leading companies in the Pharma Wholesale and Distribution Market, 2021 to 2031, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Alfresa Holdings
• AmerisourceBergen Corporation
• Cardinal Health, Inc.
• China Resources Pharmaceutical Group Limited
• CR Pharmaceutical
• CuraScript SD
• Fortissa
• Mutual Drug Company
• Mawdsley-Brooks
• Morris and Dickson
• Medipal Holdings Corporation
• McKesson Corporation
• PHOENIX Group
• Prodigy Health
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd
• Sinopharm Group Co. Ltd
• Smith Drug Company
• Suzuken Co Ltd
• Walgreens Boots Alliance, Inc.
Overall world revenue for Pharma Wholesale and Distribution Market, 2021 to 2031 in terms of value the market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Pharma Wholesale and Distribution Market, 2021 to 2031 Market report helps you?
In summary, our 450+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Pharma Wholesale and Distribution Market, 2021 to 2031 Market, with forecasts for Type, Distributor Type, Product Type each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 4 regional and 17 key national markets – See forecasts for the Pharma Wholesale and Distribution Market, 2021 to 2031 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 19 of the major companies involved in the Pharma Wholesale and Distribution Market, 2021 to 2031 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Pharma Wholesale and Distribution Market, 2021 to 2031 Market and leading companies. You will find data, trends and predictions.
'
1. Report Overview
1.1 Introduction to Pharma Wholesale and Distribution Market
1.2 Global Pharma Wholesale and Distribution Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Pharma Wholesale and Distribution Market Definition
1.6 Why You Should Read This Report
1.7 What This Report Delivers
1.8 Key Questions Answered By This Analytical Report Include:
1.9 Who is This Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Reports
1.13 About
2 Executive Summary
3 Pharma Wholesale and Distribution Industry Structure
3.1 Overview
3.2 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
3.2.1 Full-Line Wholesalers (FLWs)
3.2.2 Short-Line Wholesalers (SLWs)
3.3 The Chain of Distribution: Wholesalers vs. Logistic Service Providers
3.3.1 Secondary Wholesalers
3.3.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
3.3.3 Major Wholesalers: Distribution of a Large Number of Products to Generate High Profits
3.3.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
3.3.5 Pharmacy Benefit Managers (PBMs):
3.4 Generative Revenue and Profit
3.4.1 Forward Buying to Avoid Price Increases
3.4.2 Fee-for-Service: A Clear Pricing Structure
3.4.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
3.4.4 Clawback: The Recovery of Reimbursement Costs by Governments
3.4.5 Parallel Trade: Different Attitudes in Europe and the US
3.5 COVID-19 And Restrictions Of Supply: Adaptation To New Problems
3.6 How The Wholesaler Makes Money From Distribution Of Drugs?
3.7 Digital Supply Chain
3.8 Wholesaling And Distribution In Low- And Middle-Income Countries
3.8.1 Creating A Healthier Wholesaler/Distributor Market
3.9 Value Added Services
3.9.1 Independent Pharmacy Services
3.9.2 Generic Sourcing Programs
3.9.3 Hub Services
3.10 Distribution
3.10.1 Costs Incurred By Distributors Pharmaceutical Distribution
3.10.2 Ordering Can Be Done Over The Phone Or Electronically
3.10.3 Value Added By Distributors
3.10.4 Wholesalers Offers Wide Range Of Commercial Services
3.11 Pharmaceutical Distribution Ecosystem
3.11.1 Direct Role In Ensuring That Patients Have Access To Pharmaceuticals
3.11.2 Payor
3.11.3 Ecosystem Support Access To Pharmaceuticals
3.11.4 Hidden Negotiators Help Patients Get Access To Pharmaceuticals
3.12 Market Structure Of Pharmaceutical Wholesaling And Retailing In The Europe
3.13 Market Structure in Wholesaling
3.14 Integration in Distribution
3.14.1 Horizontal Integration
3.14.2 Vertical Integration
4 Global Market Dynamics
4.1 Market Driving Factors
4.1.1 Distributors Invest Substantially In Support Of Infrastructure In The Supply Chain Just As Health Care Organisations
4.1.2 Increase In Maintenance And Cost Control
4.1.3 Connected Trends That Lay Great Importance On Individual Treatment Are The Consequence Of Personalized Care
4.2 Market Restraining Factors
4.2.1 To Be An Authorised Trading Partner, Distributors Must Be Licenced.
4.2.2 The Market Is More Affected By Disruptions To The Supply Chain Involving A Single Or Double Source Than By Numerous Sources
4.3 Opportunities in the Global Market
4.3.1 Growth Because Of Increasing Subsidised Spending Through Programmes
4.3.2 Complexity Decreasing: From Raw Data To Operating Analytics
4.3.3 Taking Advantage Of Outside Consultancy Services
4.4 Challenges in the Global Market
4.4.1 The Issues Of Day-To-Day Procedures And Cultural Standards
4.4.2 Pharmaceutical Supply Chain Is Complicated
4.5 SWOT Analysis
4.6 PEST Analysis
4.6.1 Political
4.6.2 Economical
4.6.3 Social
4.6.4 Technology
4.7 Porters Analysis
4.7.1 Competitive Rivalry
4.7.2 Bargaining Power Of Suppliers
4.7.3 Bargaining Power Of Customers
4.7.4 Threat Of New Entrants
4.7.5 Threat Of Substitutes
5 Global Pharma Wholesale and Distribution Market Analysis
5.1 Global Market Outlook
5.1.1 The World Pharmaceutical Wholesale and Distribution Market, Restricted by Government Price Reductions and Generic Substitution
5.2 Global Market Size Estimation and Forecast
5.2.1 Pre-COVID-19 Market Scenario
5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5.3 Regional Market Size Estimation and Forecast
5.3.1 Pre-COVID-19 Market Scenario
5.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast by Type
6.1 Segment Overview
6.1.1 Full-Line Wholesalers (FLWs)
6.1.2 Short-Line Wholesalers (SLWs)
6.1.3 Direct-to-Pharmacy (DTP)
6.1.4 Hospitals, Clinics & Others
6.1.5 Mail Orders
6.1.6 Other Types
6.2 Pre-COVID-19 Market Scenario
6.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast by by Distributor Type
7.1 Segment Overview
7.1.1 Ethical/Branded Pharma Products Distributors
7.1.2 Generic Pharma Products Distributors
7.1.3 Propaganda Cum Distribution (PCD) Franchise
7.1.4 OTC/Institutional Supply Pharma Distributors
7.1.5 Other Distributor Type
7.2 Pre-COVID-19 Market Scenario
7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and Forecast by Product Type
8.1 Segment Overview
8.1.1 Prescription Drugs Wholesaling & Distribution
8.1.2 OTC Products Wholesaling & Distribution
8.1.3 Antibiotics Wholesaling & Distribution
8.1.4 Antiseptics Wholesaling & Distribution
8.1.5 Supplement Products Wholesaling & Distribution
8.1.6 Other Product Type
8.2 Pre-COVID-19 Market Scenario
8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 North America Pharma Wholesale and Distribution Market Analysis
9.1 North America Market Outlook
9.2 North America Market Size Estimation and Forecast
9.2.1 Pre-COVID-19 Market Scenario
9.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9.3 Country Market Size Estimation and Forecast
9.3.1 Pre-COVID-19 Market Scenario
9.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9.4 North America Market Size Estimation and Forecast by Type
9.4.1 Pre-COVID-19 Market Scenario
9.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9.5 North America Market Size Estimation and Forecast by by Distributor Type
9.5.1 Pre-COVID-19 Market Scenario
9.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9.6 North America Market Size Estimation and Forecast by Product Type
9.6.1 Pre-COVID-19 Market Scenario
9.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9.7 US Pharma Wholesale and Distribution Market Analysis
9.7.1 The Leading National Markets: the US Dominates in 2020
9.7.2 The US Pharma Wholesale and Distribution Market
9.7.3 Legislation to Prevent Counterfeit Drugs Can Differ Between States
9.7.4 Pre-COVID-19 Market Scenario
9.7.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9.8 Canada Pharma Wholesale and Distribution Market Analysis
9.8.1 Development of Wholesaling and Distribution in Canada
9.8.2 Pre-COVID-19 Market Scenario
9.8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9.9 Mexico Pharma Wholesale and Distribution Market Analysis
9.9.1 Pre-COVID-19 Market Scenario
9.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Europe Pharma Wholesale and Distribution Market Analysis
10.1 The Leading European (EU5) Pharma Wholesale and Distribution Markets
10.1.1 The Difference Between the US and European Markets
10.2 Europe Market Size Estimation and Forecast
10.2.1 Pre-COVID-19 Market Scenario
10.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.3 Country Market Size Estimation and Forecast
10.3.1 Pre-COVID-19 Market Scenario
10.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.4 Europe Market Size Estimation and Forecast by Type
10.4.1 Pre-COVID-19 Market Scenario
10.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.5 Europe Market Size Estimation and Forecast by by Distributor Type
10.5.1 Pre-COVID-19 Market Scenario
10.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.6 Europe Market Size Estimation and Forecast by Product Type
10.6.1 Pre-COVID-19 Market Scenario
10.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.7 Germany Pharma Wholesale and Distribution Market Analysis
10.7.1 Healthcare Reform In Germany
10.7.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
10.7.3 Pre-COVID-19 Market Scenario
10.7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.8 UK Pharma Wholesale and Distribution Market Analysis
10.8.1 Development Extensive Networks In The United Kingdom
10.8.2 Price Cuts in the UK
10.8.3 Pre-COVID-19 Market Scenario
10.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.9 France Pharma Wholesale and Distribution Market Analysis
10.9.1 The Laws Implemented In France For The Wholesale Distribution Of Pharmaceuticals And Therapeutic Items
10.9.2 Pre-COVID-19 Market Scenario
10.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.10 Italy Pharma Wholesale and Distribution Market Analysis
10.10.1 The Significant Development In Italian Pharmaceutical Sector In Recent Years
10.10.2 Pre-COVID-19 Market Scenario
10.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.11 Spain Pharma Wholesale and Distribution Market Analysis
10.11.1 Full Line Wholesalers Are The Key Actors In The Spanish Pharmaceutical Distribution Industry
10.11.2 Pre-COVID-19 Market Scenario
10.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10.12 Rest of Europe Pharma Wholesale and Distribution Market Analysis
10.12.1 Pre-COVID-19 Market Scenario
10.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Asia-Pacific Pharma Wholesale and Distribution Market Analysis
11.1 Asia-Pacific Market Outlook
11.2 Asia-Pacific Market Size Estimation and Forecast
11.2.1 Pre-COVID-19 Market Scenario
11.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.3 Country Market Size Estimation and Forecast
11.3.1 Pre-COVID-19 Market Scenario
11.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.4 Asia-Pacific Market Size Estimation and Forecast by Type
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.5 Asia-Pacific Market Size Estimation and Forecast by by Distributor Type
11.5.1 Pre-COVID-19 Market Scenario
11.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.6 Asia-Pacific Market Size Estimation and Forecast by Product Type
11.6.1 Pre-COVID-19 Market Scenario
11.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.7 China Pharma Wholesale and Distribution Market Analysis
11.7.1 Regulatory Aspects In China
11.7.2 Pre-COVID-19 Market Scenario
11.7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.8 India Pharma Wholesale and Distribution Market Analysis
11.8.1 Various Strategies & Intitative Taken In India For Pharmaceutical Businesses
11.8.2 Pre-COVID-19 Market Scenario
11.8.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.9 Japan Pharma Wholesale and Distribution Market Analysis
11.9.1 Strategies Adopted in Japan For Entering In Pharma Wholesale & Distribution
11.9.2 Pre-COVID-19 Market Scenario
11.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.10 South Korea Pharma Wholesale and Distribution Market Analysis
11.10.1 In South Korea The Focus On Their Primary Strengths Of R&D And Marketing
11.10.2 Pre-COVID-19 Market Scenario
11.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.11 Australia Pharma Wholesale and Distribution Market Analysis
11.11.1 Increased Demand Across Australia For Many Of The Thousand Pharmacies In 2020
11.11.2 Pre-COVID-19 Market Scenario
11.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.12 Rest of Asia-Pacific Pharma Wholesale and Distribution Market Analysis
11.12.1 Pre-COVID-19 Market Scenario
11.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 LAMEA Pharma Wholesale and Distribution Market Analysis
12.1 LAMEA Market Outlook
12.2 LAMEA Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 LAMEA Market Size Estimation and Forecast by Type
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 LAMEA Market Size Estimation and Forecast by by Distributor Type
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 LAMEA Market Size Estimation and Forecast by Product Type
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 Brazil Pharma Wholesale and Distribution Market Analysis
12.7.1 Brazil: Pharma and Wholesale Distribution Market
12.7.2 Pre-COVID-19 Market Scenario
12.7.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 South Africa Pharma Wholesale and Distribution Market Analysis
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 Saudi Arabia Pharma Wholesale and Distribution Market Analysis
12.9.1 Distribution and Wholesale Regulations in Saudi Arabia
12.9.2 Pre-COVID-19 Market Scenario
12.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 Turkey Pharma Wholesale and Distribution Market Analysis
12.10.1 Distribution and Wholesale Regulations in Turkey
12.10.2 Pre-COVID-19 Market Scenario
12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 UAE Pharma Wholesale and Distribution Market Analysis
12.11.1 Distribution and Wholesale Regulations in UAE
12.11.2 Pre-COVID-19 Market Scenario
12.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Rest of LAMEA Pharma Wholesale and Distribution Market Analysis
12.12.1 Pre-COVID-19 Market Scenario
12.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Leading Company Profiles
13.1 Morris and Dickson
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Company Product Benchmarking
13.2 Alfresa Holdings
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Company Financial Profile (2017-2021)
13.2.4 Company Product Benchmarking
13.2.5 Company Recent Developments
13.3 Walgreens Boots Alliance, Inc
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Company Financial Profile (2016-2020)
13.3.4 Company Product Benchmarking
13.3.5 Company Recent Developments
13.4 AmerisourceBergen Corporation
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Company Financial Profile (2016-2020)
13.4.4 Company Product Benchmarking
13.4.5 Company Recent Developments
13.5 Sinopharm Group Co. Ltd
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Company Financial Profile (2016-2020)
13.5.4 Company Product Benchmarking
13.5.5 Company Recent Developments
13.6 Suzuken Co Ltd
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Company Financial Profile (2017-2021)
13.6.4 Company Product Benchmarking
13.6.5 Company Recent Developments
13.7 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Company Financial Profile (2016-2020)
13.7.4 Company Product Benchmarking
13.7.5 Company Recent Developments
13.8 China Resources Pharmaceutical Group Limited
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Company Financial Profile (2016-2020)
13.8.4 Company Product Benchmarking
13.8.5 Company Recent Developments
13.9 Smith Drug Company
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Company Product Benchmarking
13.10 CuraScript SD
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Company Product Benchmarking
13.11 Cardinal Health, Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Company Financial Profile (2016-2020)
13.11.4 Company Product Benchmarking
13.11.5 Company Recent Developments
13.12 Mutual Drug Company
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Company Product Benchmarking
13.13 CR Pharmaceutical
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Company Financial Profile (2016-2020)
13.13.4 Company Product Benchmarking
13.13.5 Company Recent Developments
13.14 McKesson Corporation
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Company Financial Profile (2017-2021)
13.14.4 Company Product Benchmarking
13.14.5 Company Recent Developments
13.15 Medipal Holdings Corporation
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Company Financial Profile (2017-2021)
13.15.4 Company Product Benchmarking
13.15.5 Company Recent Developments
13.16 PHOENIX Group
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Company Financial Profile
13.16.4 Company Product Benchmarking
13.16.5 Company Recent Developments
13.17 Mawdsley-Brooks
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Company Product Benchmarking
13.18 Prodigy Health
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Company Product Benchmarking
13.19 Fortissa
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Company Product Benchmarking
14 Conclusion and Recommendations
14.1 Conclusion Summary
14.2 Recommendations
14.2.1 Reduction In The Layers Of Distribution
14.2.2 More Market-Friendly Regulations
14.2.3 Technological Innovation
15 Glossary Terms
List of Tables
Table 1. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 2. Global Pharma Wholesale and Distribution Market Snapshot, 2021 & 2031 (US$million, CAGR %)
Table 3. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 4. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 5. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 6. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 7. Global Pharma Wholesale and Distribution Market Forecast, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 8. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 9. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 10. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 11. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 12. Global Pharma Wholesale and Distribution Market by Region, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 13. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 14. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 15. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 16. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 17. Global Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 18. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 19. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 20. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 21. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 22. Global Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 23. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 24. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 25. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 26. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 27. Global Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 28. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 29. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 30. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 31. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 32. North America Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 33. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 34. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 35. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 36. North America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 37. orth America Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 38. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 39. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 40. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 41. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 42. North America Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 43. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 44. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 45. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 46. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 47. North America Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 48. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 49. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 50. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 51. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 52. US Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 53. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 54. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 55. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 56. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 57. Canada Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 58. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 59. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 60. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 61. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 62. Mexico Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 63. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 64. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 65. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 66. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 67. Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 68. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 69. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 70. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 71. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 72. Europe Pharma Wholesale and Distribution Market by Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 73. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 74. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 75. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 76. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 77. Europe Pharma Wholesale and Distribution Market by Distributor Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 78. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 79. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 80. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 81. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 82. Europe Pharma Wholesale and Distribution Market by Product Type, 2021-2031 (USD Bn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 83. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 84. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 85. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 86. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 87. Germany Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 88. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 89. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 90. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 91. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 92. UK Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 93. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 94. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 95. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 96. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 97. France Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 98. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 99. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 100. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 101. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 102. Italy Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 103. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 104. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 105. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 106. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 107. Spain Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 108. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 109. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 110. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 111. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 112. Rest of Europe Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 113. Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2021-2031 (USD Bn, AGR (%), CAGR(%))
Table 114. Asia-Pacific Pharma Wholesale and Distribution Market by Va
